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Abstract
Umu test have been widely used to predict the detection and assessment of DNA- damaging chemicals in
environmental genotoxicity field for three decades. This test system is more useful with respect to simplicity,
sensitivity, rapidity, and reproducibility. A review of the literature on the development of the umu test is
presented in this article. The contents of this article are included a description of numerous data using the
umu test. This test have been fully evaluated and used in many directions. Different genetically engineered
umu systems introducing bacterial and rat or human drug metabolizing enzymes into the umu tester strains,
have been successfully established and are considered as useful tools for genotoxicity assays to study the
mechanisms of biotransformation in chemical carcinogenesis. Actually, we developed that two types of
bacterial metabolizing enzymes and 4 types of rat and human metabolizing enzyme DNAs are expressed in
these strains such as nitroreductase and O-acetyltransferase, cytochrome P450, N-acetyltransferases,
sulfotransferases, and glutathione S-transferases, respectively. Due to increasing numbers of minute
environmental samples and new pharmaceuticals, a high-throughput umu test system using Salmonella
typhimurium TA1535/pSK1002, NM2009, and NM3009 strains provides a useful for these genotoxicity screening.
I also briefly describe the first attempts to incorporate such umu tester strain into photo-genotoxicity test.
Keywords: umu test, SOS response, Metabolic activation, Genotoxicity, Cytochrome P450, Glutathione
S-transferase, O-acetyltransferase, Sulfotransferase
Background
Since 1970, a variety of bacterial genotoxicity assays have
been developed using Escherichia coli and Salmonella
enterica serovar Typhimurium (S. typhimurium) tester
strains. They have played an important role in testing and
monitoring carcinogenic chemicals, screening novel
synthesized compounds, and monitoring environmental
samples. In the early 1970s, Ames test, called Salmonella/
microsome assay [1, 2] is one of the most useful methods
for screening of environmental chemical carcinogens. This
test was based on the measure of the reverse mutations
from histidine auxotrophy to prototrophy in several
constructed Salmonella tester strains.
During 10 years, newly three genotoxicity assays such as
the Biochemical prophage induction assay [3], SOS
Chromotest [4], and umu test [5] have been developed
with different principles. The umu test is based on the
abilities of DNA-damaging agents to induce expression of
the umuC gene responsible for SOS mutagenesis induced
by radiation or chemical agents in E. coli [6], the umuC
gene is regulated by the lexA and recA genes of bacterial
SOS response. In 1982, we began studying on the develop-
ment of short-term test for detecting environmental
mutagens and carcinogens using S. typhimurium. We
proposed umu test in 1985, which is based on a single S.
typhimurium strain TA1535/pSK1002 harboring a multi-
copy plasmid pSK1002 with umuC"lacZ gene fusion [5].
Next, we have developed genetically engineered umu
tester strains over-expressing bacterial nitoreductase/or
O-acetyltransfease enzymes for the detection of nitro-
arenes and arylamines with highly sensitivity [7]. We
have further developed genetically engineered umu test
systems expressing human phase I drug metabolic enzyme
(cytochrome P450) [8] and rat or human phase II drug
enzymes (glutathione S-transferase, N-acetyltransfearses,
and sulfotransferases) for determination of bioactivation
of chemical procarcinogens and promutagens and studies
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of mechanisms of genotoxicity or carcinogenesis [9–11].
Finally, we recently published our papers on the application
of umu test to photogenotoxicity [12] and flow cytometry
analysis [13].
In this review, I focus on some aspects of the develop-
ment and progress during three decades regarding our
scientific literatures published since 1985 with the geno-
toxicity assays using umu test and their prospects.
Principle of the umu test
When E. coli damages DNA or arrests DNA synthesis
with ultraviolet light and genotoxins, inhibition of the cell
division, prophage induction, DNA repair, and mutage-
nesis are induced [14]. These cellular functions are called
an SOS response [14]. Regulation of the SOS response is
mediated through the recA and lexA genes [15]. The SOS
genes consist of approximately 30 unlinked genes [16].
When cells are exposed to chemical carcinogen, an SOS
signal is generated and alters RecA protein to an activated
form. The activated RecA protein (RecA filament) is facili-
tated the autocleavage of LexA protein, a repressor of the
SOS genes. This autocleavage inactivates the transcrip-
tional repressor activity of LexA, thus leading to induction
of the SOS response. After the cell damage is repair, the
level of signal drops and RecA protein is no longer acti-
vayed. LexA repressor then accumulates and the SOS
genes are again repressed under normal condition. This
SOS regulation is considered as adaptive response mecha-
nisms to lead a cell survival if repair is completed.
In the event that DNA lesions in E. coli cannot be repair
accurately, an error-prone replication pathway exists. This
pathway, named translesion DNA synthesis (TLS), is the
mechanistic basis of SOS mutagenesis [17]. This TLS in E.
coli depends on the products of the recA and umuDC
genes [14]. The umuDC genes encode a DNA polymerase
(DNA Pol V), able to replicate over abasic sites [18],
thymine-thymine cyclobutane dimmers, and pyrimidine-
pyrimidone [6–4] photoproducts [19].
The umuC gene is controlled by the recA and lexA
genes. Shinagawa et al. [20] constructed by the fusion of
umu operon to a reporter lacZ gene. The umu test using
S. typhimurium TA1535/pSK1002 is assay systems based
on a self-cleavage reaction of the LexA representative
repressor protein and the fusion of the umu-controlled
promoter with the lacZ gene that can be colorimetrically.
The principle of the umu test is as followed: when the
SOS response is induced by genotoxins, the umuC"lacZ
fused gene which is under the promoter’s control of an
umuDC gene is expressed, and UmuC"LacZ fused protein
of the product is induced. Because this protein has a
β-galactosidase activity, it’s possible to check the inducti-
vity of the umuC gene expression by measuring this
activity. As the result, the DNA-damaging capability due
to the chemicals can be supposed easily. Schema of the
principle of umu test is presented in Fig. 1.
Fig. 1 Schema showing the principle of umu test using umuC”lacZ fusion gene. In uninduced cells, the LexA repressor protein, acts to repress by
binding to operator sequences (called an SOS box) upstream from umu operon. On the other hand, in induced cells: when the DNA is damaged
by genotoxins, or when replication is blocked by various ways, the cell induces an SOS signal. The SOS signal activates a coprotease activity of
the RecA protein, and this protease (RecA filaments) activate the autocleavage of the LexA repressor, allowing umuC” lacZ fusion gene expression,
and the chimeric UmuC”LacZ fused protein is produced. Since the umuC gene is fused with the lacZ gene for β-galactosidase activity, the induc-
tion of umuC gene can be estimated by determination of the β-galactosidase activity
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Development and evaluation of genotoxicity using umu
test
We first presented the umu test in 1982. Our first paper
published from Mutation Research in 1985 has been cited
about 600 times. In addition, the test strain for umu test
has been distributed to more than 350 laboratories world-
wide so far. We further studied the abilities of 151 chemi-
cals to induce umuC gene expression in S. typhimurium
TA1535/pSK1002 [21]. Data presented that some of the
chemicals such as dimethyl sulfoxide, m-dioxan, 5-fluorou
racil, and paraquat, which have been reported to be non-
mutagenic in Ames test, were found out to be positive in
umu test. Reifferscheid and Heil [22] further compared
the results obtained in umu test with those obtained in
the Ames test for the available data of 486 compounds.
The concordance between the umu test and Ames test re-
sults was about 90 %. In addition, the agreement between
carcinogenesis and umu response was 65 %. The umu test
results were highly representative of rodent carcinoge-
nicity [22] (Table 1). Furthermore, Yasunaga et al. [23]
examined the genotoxicity of 83 National Toxicology
Program (NTP) chemicals including noncarcinogens and
carcinogens in the umu test. The concordance (67 %) in
umu test and carcinogenicity test was similar to that (63 %)
in the Ames test and carcinogenicity test. Furthermore, the
umu test has been successfully applied to screen for the
presence of genotoxic substances in a broad range of mate-
rials and environments such as new drugs, foods, cosmetic
products, and working environment as well as to detect the
genotoxic effects of radiations and anti-genotoxic com-
pounds so far.
In Japan, umu test has already been adopted as an official
method for water test method in 1993 and the wastewater
test method in 1997. Following several modifications, it is
used as German standard methods [24] for the examination
of water and wastewater testing in 1995. The umu test has
become the only reporter gene assay to achieve Inter-
national standardization organization (ISO) standards so far
[25]. Similarly, it has been approved as genotoxicity test for
wastewater in Malaysian standard method (MS ISO 13829:
2008). An adoptions of the umu test for official method
was shown in Table 2.
Very recently, new electrochemical genotoxicity assays,
which enable the analysis of turbid samples, have been
developed [26–28]. They are based on the umu test using a
rotating disk electrode in a microtiter droplet. The results
revealed that the signal detection in these assays due to
hydrodynamic voltametry was less influenced by the pres-
ence of colored components and sediment particles in the
samples compared to the usual colorimetric detection.
Brinkmann and Eisentraeger [29] showed that the auto-
mated umu test is highly applicable for the assessment of
non-volatile samples with strong or moderate genotoxic
effects using a RoboSeqR 4204 SE pipetting station. In
1986, the umu test was first commercialized in the form
of a package kit. Very recently, we have developed a new
umu test kit named as Umulac ATR using S. typhimurium
NM2009 strain (available from Protein Purify Co. Ltd).
Development of tester strains that can detect nitroarenes
and arylamines with high sensitivity
Since bacteria such as E. coli and S. typhimurium using
genotoxicity assays have little capacity for bioactivation
of chemicals, the assays are indispensable to the use of
exogenous mammalian enzyme systems such as S9 frac-
tion. However, in case of certain classes of nitroarene com-
pounds and arylamines, bacterial enzymes are greatly
responsible for the bioactivation. Carcinogenic nitroarenes
were activated to genotoxins by reduction to arylhydroxy-
lamine intermediates by bacterial nitroreductase. These
arylhydroxylamine derivatives are further activated by
O-acetyltransferase (O-AT) to form the ultimate reactive
electrophiles in bacterial or mammalian cell systems
[30, 31]. Most of arylamines are metabolized essentially
through two steps: N-oxydation by cytochrome P450 en-
zymes, and acetyl coenzyme A-dependent acetylation by
N,O-acetyltransferase [32, 33]. In 1993, we have improved
the sensitivity of carcinogenic nitroarenes and arylamines
by making the drug-metabolizing enzyme overproducing
in the bacterial cell: I subcloned the nitroreductase (NR)
Table 1 Comparison of umu test results and chemicals tested
for rodent carcinogenicity [22]
Carcinogenicity umu test
+ — ± Total
+ 119 72 2 193
— 11 39 0 50
± 0 5 0 5
Total 130 116 2 248
Sensitivity 65 % (119/193)
Specificity 78 % (39/50)
Accuracy 65 % (158/243)
Table 2 Standard methods for the determination of the
genotoxicity of water and wastewater using umu test
Year Description Country
1993 An official method of the water supply test method Japan
1995 A standard method of the genotoxicity of water and
wastewater (DIN 38415T3) [24]
Germany
1997 An official method of the wastewater test method Japan
2000 A genotoxicity test of water and wastewater in
International standardization Organization (ISO)
Standards (ISO/CD 13829) [25]
ISO
2008 A standard method of the genotoxicity of water
and wastewater (MS ISO13829)
Malaysia
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gene or both NR and O-AT genes into plasmid vector
pACYC184, and developed new tester strains NM2009 and
NM3009, which overproduced bacterial O-AT and NR/O-
AT, respectively [7, 34, 35] (Table 3). Among six tester
strains, NM3009 showed the highly sensitivity to chemical
carcinogens such as 1-nitronaphthalene, 2-nitrofluorene,
3,7-dinitrofluoranthene, 3-nitrofluoranthene, 5-nitroacena
phthene, 2-nitronaphthalene, 1-nitropyrene, 1,6-dinitro-
pyrene, 3,9-dinitrofluoranthene, 4,4′-dinitophenyl, 1,8-
dinitropyrene, m-dinitrobenzene, 2,4-dinitrotoluene, and
1,3-dinitropyrene. We demonstrated that strain NM3009
enhanced the sensitivity in detecting genotoxic nitroarenes
[7] (Table 4). These highly sensitive tester strains provide
many advantages for the detection of genotoxic activities
of nitroarenes in environmental samples as well as for
studies of mechanisms of activation of these compounds.
Since 1995, we demonstrated that the NM2009 having
an O-AT-overexpressing activity is highly sensitive to
carcinogenic arylamines and aminoazo compounds and
heterocyclic amines, when compared with the parental
strain TA1535/pSK1002 and the O-AT-deficient strain
NM2000 [36] (Table 4) and revealed that NM2009 strain
provides a very useful to detect the genotoxic effects of
potential genotoxic arylamines above, which require meta-
bolic activation via the P450/ acetyltransferase systems.
Numerous studies have also been reported that umu test
using liver microsomal P450-linked monooxygenase sys-
tems in NM2009 strain allows the analysis of roles of rat
and human P450s in the bioactivation of various carcino-
gens [37–42]. Shimada et al. [43] examined the catalytic
properties of human P450 1B1 for carcinogen activation
using recombinant P450 1B1 in yeast microsomes. The
results indicated that P450 1B1 is involved in the bioacti-
vation of various procarcinogenic chemicals to DNA-
damaging products in the umu assay using S. typhimur-
ium NM2009. They also compared activities of metabolic
activation of a number of polycyclic aromatic hydro-
carbons (PAHs), and PAH dihydrodiols and other procar-
cinogens by recombinant human P450 enzymes using
umu assay. The results supported the importance of P450
1A1 and P450 1B1 in the activation of PAHs and PAH
dihydrodiols; other P450 enzymes such as P450 1A2, 2C9,
and 3A4 have abilities to catalyze PAH chemicals at much
slower rates [44]. Recently, Shimada et al. [45] examined
the metabolic activation of PAHs and aryl- and hetero-
cyclic amines to genotoxic products in S. typhymurium
NM2009 and showed that P450 2A13 and 2A6 were able
to activate several of these procarcinogens. The former
two enzymes were especially active in catalyzing the acti-
vation of 2-aminoanthracene (2-AA) and 2-aminofluorene
Table 3 Establishment of umu tester strains overexpressing
bacterial and mammalian metabolic enzymes









[7, 35, 70, 71]
OY1002/1A1 Human P4501A1 and NPR,
and O-AT overexpressing
PAH, Arylamines [8, 70]
OY1002/1A2 Human P4501A2 and NPR,
and O-AT overexpressing
Arylamines [8, 51, 70]
OY1002/1B1 Human P4501B1 and NPR,
and O-AT overexpressing
PAH, Arylamines [8, 70]
OY1002/2C9 Human P4502C9 and NPR,
and O-AT overexpressing
[8, 70]
OY1002/2D6 Human P4502D6 and NPR,
and O-AT expressing
[8, 70]
OY1002/2E1 Human P4502E1 and NPR,
and O-AT overexpressing
Nitrosoamines [8, 70]




























NPR, NADPH-P450 reductase; O-AT, O-acetyltransferase; PAH, polycyclic
aromatic hydrocarbon
Table 4 Comparison of the sensitivity of NM2009, NM3009, and
TA1535/pSK1002 strains to nitroarenes and arylamines [7, 36]
Chemicals S9 TA1535/pSK1002 NM2009 NM3009
Minimal concentration (ng/ml)a
1-nitropyrene − 13 ND 0.2
3-nitrofluoranthene − 10 ND 0.08
1,3-dinitropyrene − 0.4 ND 0.1
1,6-dinitropyrene − 1.4 ND 0.04
3,7-dinitrofluoranthene − 1.2 ND 0.05
3,9-dinitrofluoranthene − 1.8 ND 0.06
2-aminoanthracene + 8,400 400 ND
6-aminochrysene + 200 260 ND
Glu-P-1 + 100 80 ND
Trp-P-1 + 80 6 ND
MeAαC + 800 180 ND
MeIQ + 1 0.009 ND
aThe concentration of chemicals that induced umuC gene expression by
twofold over background levels
ND, not determined
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(2-AF). The results suggested that P450 2A enzymes, as
well as P450 family enzymes including P450 1B1, are major
enzymes involved in activating PAHs and aryl- and hetero-
cyclic amines as well as tobacco-related nitrosamines.
As deactivation works using umu assay, Shimada et al.
[46] have studied that the effects of several organosele-
nium compounds 1,2-, 1,3-, and 1,4-phenylenebis(methy-
lene)selenocyanate (XSCs) as well as inorganic sodium
selenite on the activities of xenobiotic oxidation and
procarcinogenic activation by human liver microsomes
and by recombinant human P450 1A1, 1A2, and 1B1
enzymes using NM2009 strain. The three XSCs were
found to be very potent inhibitors of metabolic activation
of 3-amino1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1),
2-amino-3,5-dimethylimidazo[4,5-f]quinoline (MeIQ) and
2-AA, catalyzed by P450 1A1, 1A2, and 1B1, respectively.
These inhibitory effects may, in part, account for the
mechanisms responsible for cancer prevention by organo-
selenium compounds in laboratory animals. In addition,
they examined if individual PAHs and other procarcino-
gens affect the activities of human P450 1A1, and 1A2,
1B1 by measuring 7-ethoxyresorufin O-deethylation acti-
vity and metabolism activation of PAH dihydrodiols and
MeIQ to genotoxic metabolites in umu assay. The results
revealed that three selected PAHs (5-methylchrysene,
B[a]P, and B[a]A) inhibited metabolic activation of 5-
methylchrysene-1,2-diol, (+/−)-B[a]P-7,8-diol, dibenzo[a,l]
pyrene-11,12-diol, and MeIQ to genotoxic metabolites
catalyzed by P450 1A1, 1A2, and 1B1 in S. typhimurium
NM2009 [47]. Recently, we examined the abilities of
naturally occurring furanocoumarins such as isoimpe-
ratorin, imperatorin, (+)-oxypeucedanin, (+)-byakange-
licol, and (+)-byakangelicine to suppress carcinogens- and
procarcinogens-induced DNA damages using umu assay
and also evaluated the abilities of these compounds to
inhibit human and rat P450 1A enzymes in vitro [48].
The results suggested that isoimperatorin, imperatorin,
(+)-oxypeucedanin, (+)-byakangelicol, and (+)-byakan-
gelicine significantly suppressed 2-[2-(acetylamino)-4-
amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2-H
-bcenzo-triazole- and MeIQ-induced genotoxicities. The
mechanism on these anti-genotoxic effects might be due
to the inhibition of metabolic activation of procarcinogens
catalyzed by P450 1A1 and 1A2. In conclusion, we sug-
gested that SOS activation and deactivation assays using
umu strains can be evaluated a variety of genotoxic carcin-
ogens in terms of the catalytic specificity of mammalian
P450 enzymes toward their activation.
UDP-glucuronosyltransferases (UGTs) are important
enzymes that detoxicate many procarcinogens. The pro-
carcinogens, which undergo bioactivation by P450-directed
oxidation, become good substrates for the UGTs. To
analyze if glucuronidation contributes to the elimination of
P450-mediated reactive intermediate metabolites to prevent
a toxic event, Yueh et al. [49] examined for their ability of
11 human UGTs to modulate the genotoxic actions of N-
hydro-2-acetylaminofluorene (N-hydroxy-2-AAF) and
2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(N-hydroxy-PhIP) formed by P450 1A2 with umu assay
using S. typhimurium NM2009. In the presence of uridine
5′-diphosphoglucuronic acid, UGT 1A9 inhibited the gen-
otoxicity of N-hydroxy-2-AAF when incubated at 25 μM
and completely abolished the genotoxicity at lower con-
centrations. However, the genotoxicity of N-hydroxy-PhIP
did not be interfered by the UGT 1A9. This may be due to
the dramatic differences in the formation of UGT 1A9
generated glucuronide.
Development of a new genotoxicity test system with umu
tester strains expressing phase I and phase II human drug
metabolizing enzymes
Numerous genotoxic compounds are metabolically acti-
vated by phase I and phase II drug-metabolizing enzymes
(DMEs) to electrophilic species which covalently bind to
DNA and produced the genotoxic/mutagenic activity. The
DMEs can be classified into two main groups: oxidative or
conjugative. The cytochrome P450/ NADPH-cytochrome
P450 reductase involved in the phase I drug metabolism
first modify these compounds with functional groups by
oxidation, reduction and hydrolysis. Furthermore, the
phase I intermediates are metabolized by glutathione
S-transferases, acetyltransferases and sulfotransferases
involved in phase II drug metabolism.
Human cytochrome P450s
In order to develop an alternative method (s) to overcome
the species differences and to evaluate bioactivation of
chemicals in humans, I first established many new umu
tester strains expressed phase I human cytochrome P450
monooxygenase (P450). The strain was constructed by
introducing plasmid pCW’/1A2: hNPR (carrying cDNAs of
P450 1A2 and NADPH-P450 reductase in the isopropyl-a-
D-thiogalactoside (IPTG)-inducible biocistronic construct)
and pOA101 (carrying umuC”lacZ fusion gene) into
S. typhimurium TA1535. The newly developed tester strain
S. typhimurium OY1001/1A2 was found to activate hete-
rocyclic amines (e.g., 2-amino-3-methylimidazo[4,5-f]quin-
oline (IQ), MeIQ and 2-amino-3,8-dimethylimidazo[4,5-
f]quiloline (MeIQx)) to reactive metabolites that induce
umuC gene expression in a concentration-dependent man-
ner without S9 fraction. We demonstrated that the estab-
lished strain OY1001/1A2 could be of use for the detection
of the genotoxicity of arylamines without the addition of
metabolic activation enzymes [50]. To further enhance the
sensitivity of the strain towards procarcinogenic heterocy-
clic aromatic amines (HCAs), we developed S. typhi-
murium OY1002/1A2 by introducing pCW”/1A2:hNPR
(bicistronic construct co-expressing human P4501A2 and
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the reductase) and pOA102 (constructed by subcloning
the Salmonella O-AT gene in the pOA101-expressing
umuC"lacZ gene) in S. typhimurium TA1535. In addition,
we developed an O-AT-deficient strain, the OY1003/1A2,
coexpressing human P450 1A2 and reductase. By using
strains OY1001/1A2, OY1002/1A2, and OY1003/1A2, we
compared the induction of umuC gene expression by
HCAs and found that the OY1002/1A2 strain was more
sensitive than the OY1001/1A2 strain towards HCAs, but
not detected with the OY1003/1A2 strain. These results
indicated that strain OY1002/1A2 can be used in detec-
ting potential genotoxic arylamines requiring bioactivation
by P450 1A2 and O-AT [51].
To clarify roles of different P450 enzymes in the bioacti-
vation of HCAs and other procarcinogens, we selected
seven of the major human P450 enzymes: P450 1A1, 1A2,
1B1, 2C9, 2D6, 2E1, and 3A4. I further established seven
strains OY1002/1A1, OY1002/1A2, OY1002/1B1, OY1002/
2C9, OY1002/2D6, OY1002/2E1, and OY1002/3A4 by
introducing two plasmids into S. typhimurium TA1535,
one carrying both P450 and the reductase cDNAs in a
bicistronic construct under control of an IPTG-inducible
double tac promoter and the other, pOA102, carrying
O-AT and umuC”lacZ fusion genes [8] (Table 3). An
outline of the umu test systems is shown in Fig. 2. Among
all homo- and heterocyclic aromatic amines examined,
2-aminoanthracene (2-AA), 2-aminofluorene (2-AF), 2-
amino-6-methyl-dipyrido[1,2-a:3′, 2′-d]imidazol (GluP-1),
MeIQx, MeIQ, and IQ showed strong genotoxicity in the
OY1002/1A2 strain, and the genotoxicity of IQ and 2-AA
was detected in the OY1002/1A1 strain. Aflatoxin B1
showed genotoxicity in the OY1002/1A2, OY1002/1A1,
and OY1002/3A4 strains. However, β-naphthylamine and
B[a]P could not detect genotoxicity in any of the strains.
These results indicated that the P4501A2 is the major
enzyme involved in the metabolic activation of HCAs [8].
These strains could provide a useful tool for studying the
roles of human P450 enzymes involved in biotransfor-
mation of xenobiotic compounds. Recently, we found that
these strains can show the possibility of a high-throughput
umu test system (under submitted).
Many other researchers have also reported mutageni-
city studies using genetically engineered bacterial strains
expressing human P450s; Josephy et al. [52] introduced
the expression plasmid carrying human P450 1A2 into S.
typhimurium YG1019 strain to detect the mutagenicity
of HCAs and arylamines, and reported that the mutage-
nicity of 2-AA and 2-AF was detectable with this system.
Kranendonk et al. [53] reported on the development
of an E. coli strain (BMX100), which expressed active
human P450 1A2, alone or fused to rat liver NADPH-P450
reductase. Suzuki et al. [54] developed S. typhimurium
TA1538/ARO strain by introducing an expression plasmid
(p1A2OR) carrying human P450 1A2 and the human
NADPH-P450 reductase cDNAs and an expression
(pOAT) carrying S. typhimurium O-AT gene to S. typhi-
murium TA1538 strain to produce the TA1538/ARO strain.
TATA1538/ARO strain showed a high sensitivity to muta-
genic HCAs with concentration at around picomole order.
Also, Kushida et al. [55, 56] developed Salmonella tester
strains YG7108 2E1/OR and YG7108 2A6/OR highly sen-
sitive to promutagenic N-nitrosamines by introducing a
plasmid carrying human P450 1A6 and NADPH-P450
reductase cDNAs or human P450 2E1 and OR cDNAs, re-
spectively, into the ada− and ogt− deficient strain YG7108.
The YG7108 2E1/OR-expressing strain gives a strong
mutagenic response to N-nitrosodimethylamine (NDMA),
N-nitrosodiethylamine (NDEA), N-nitrosodipropylamine
(NDMA), N-nitrosodibutylamine (NDBA), N-nitrosopyro-
lidine (NPYR), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK), but not N-nitrosomethylphenylamine
(NMPhA), and N-nitrosonornicotine (NNN). On the other
hand, the YG7108 2A6/OR-expressing strain could detect
N-nitrosamines such as NDMA, NDEA, NDPA, NDBA,
Fig. 2 Pathway from metabolic activation to mutagenesis. P450, cytochrome P450; NR, nitroreductase; NAT, N-acetyltransferase; SULT,
sulfotransferase, GST glutathione S-transferase
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NMPhA, NPYR, NNN, and NNK. They indicated that
human P450 2E1 is mainly involved in the metabolic acti-
vation of N-nitrosamines with a relatively short alkyl
chain(s), whereas P450 2A6 was predominantly respon-
sible for the activation of N-alkylnitrosamines possessing a
relatively bulky alkyl chain(s). Similarly, Cooper and Porter
[57] have constructed two mutagenicity tester strains that
co-express full-length human P450 2E1 and P450 reduc-
tase in S. typhimurium6laking ogt and ada methyltransfer-
ase (YG7104ER, ogt - and YG7108ER, ogt−, ada−). These
strains were very sensitive to nitrosamines with longer
alkyl side chains including diethylnitrosamine, dipropylni-
trosamine and dibuthylnitrosamine. In conclusion, taking
all of these reports, obtained in the last decade into
account, the bacterial tester strains expressing human
P450s may provide a useful tool to evaluate the roles of
P450 on the metabolism of drugs and bioactivation of
xenobiotic chemicals in humans.
In addition of P450s as phase I enzyme, following phase
II enzymes such as N-acetyltransferases, sulfotransferases
and glutathione S-transferases are known to play impor-
tant roles in the metabolism of various toxic and carcino-
genic chemicals.
Rat glutathione S-transferase
Glutathione S-transferases (GSTs) are constitutively
expressed in all mammalian tissues. Cytosolic GSTs can
be classified into four groups (alpha, pi, mu, and theta) on
the basis of structural similarity of isolated genes [58].
Most of the glutathione conjugates are less toxic, but in
several cases the enzymes convert dichloromethane and
short-chain alkyl halides to unstable and genotoxic glu-
tathione conjugates [58]. I subcloned the fragment of umu
operon into a multicopy vector plasmid pKK233-2 con-
taining rat GST 5–5 gene. The tester strain S. typhimu-
rium NM5004 was developed by introducing the plasmid
(pOY100) into S. typhimurium TA1535 [9] (Table 3).
We compared sensitivity of the NM5004 and the paren-
tal strain TA1535/pSK1002 to several dihaloalkenes.
The NM5004 strain was found to detect the genotoxi-
city of ethylene dibromide, 1-bromo-2-chloroethane,
1,2-dichloroethane, and methylene dichloride (CH2CI2),
but TA1535/pSK1002 did not affected [9] (Table 5).
This result was very similar to the results reported by
Their et al. [59] who the dihaloalkanes are mutagenic in
Ames strain TA1535 which expresses rat GST protein.
Also, ten chemicals-1,2-dibromoethane, N-(2,3-epoxyp
ropyl)phthalimide, 1,3-dichloroacetone, CH2I2, 1,2-epo
xy-3-phenoxypropane, 2,3-epoxypropyl p-methoxyphe-
nyl ether, 1-bromo-2-chloroethane, 1-bromo-2,3-dichlo
ropropane, CH2BrCl, and CH2Br2-were found to enhance
umuC induction in the NM5004 as compared the parental
strain [60] (Table 5). Interestingly, we could detect the
genotoxicity of CH2CI2 in the NM5004. However, Simura
et al. [61] have reported that CH2CI2 did not be bioacti-
vated by human GST alpha and pi classes of enzymes.
This suggests that theta class GST enzyme might play a
pivotal role in the activation of CH2CI2 rather than other
GST enzymes. In contrast, in the case of 1-nitropyrene
and 2-nitrofluorene, NM5004 strain showed weaker umuC
induction than the parental strain. This result indicates that
the theta class rat GST 5-5 enzyme also involves in the
inactivation of potential environmental carcinogenic chemi-
cals. Recently, CH2CI2 and 1,2-dichloropropane are widely
used as industrial solvents. They are known to cause a
novel human bile cancer by a Japanese printing factory to
Table 5 Comparison of genotoxicity activities of various
chemicals in S. typhimurium TA1535/pSK1002 and NM5004






























4-vinylcyclohexene dioxide − −
eyclohexene oxide − −
1,2-epoxybutane − −
1-bromo-2-fluoroethane − −
a Potencies of chemicals in umu systems were ranked as follows: (−) 0–50; (±)
50–100; (+) 100–250; (++) 250–450; (+++) 450 for umu gene expression (units)
Oda Genes and Environment  (2016) 38:24 Page 7 of 14
the workers. Therefore, this strain might be able to use for
further studies of the role of the GST in human cancer risk
such as bile duct.
Human N-acetyltransferases
Numerous studies have shown that nitroarenes and aryla-
mines are present in environment or occupied places [31].
They are reported to be strong mutagens in bacteria and
carcinogens in rodents [31, 62–64]. Human N-acetyltrans-
ferase (NAT) enzyme NAT1 and NAT2, are known to be
polymorphic with rapid, intermediate and slow acetylator
phenotypes [65]. To clarify the role of two human NAT1
and NAT2 in the genotoxicity of arylamines and nitro-
arenes, we established strains NM6001 and NM6002 by
introducing human NAT1 and NAT2 cDNAs, respec-
tively, into the parental strain NM6000 (TA1538/1,8-DN
P/pSK1002) (Table 3). The human NAT1-expressing strain
NM6001 showed higher sensitivity than the human NAT2-
expressing strain NM6002 to the cytotoxic and genotoxic
effects of 2-nitrofluorene and 2-AF [10]. This result was in
good agreement with those reported by Grant et al. [66]
who showed that 2-AF exhibited the mutagenic response in
a S. typhimurium strain expressing human NAT1 in the
presence of rat liver S9. In contrast, the NM6002 strain
exhibited higher sensitivity than the NM6001 strain to the
cytotoxic and genotoxic effects by 1,8-dinitropyrene,
6-aminochrysene and MeIQ. Interestingly, we found that
the bladder carcinogenic arylamines 4-aminobiphenyl,
2-acetylaminofluorene, β-naphthylamine, o-tolidine, o-ani-
sidine, and benzidine are mainly activated by the NAT1
enzyme to produce DNA damage rather than NAT2 [67].
These results suggested that the human NAT strains can
be employed for the studies on mechanisms of genotoxi-
city of a variety of nitroarenes and arylamines, along with
the assessment of cancer risk to humans.
In the late 2000s, we have reported the roles of human
P450s and human NATs enzymes in the metabolic activa-
tion of various carcinogenic chemicals. The β-carboline
compounds norharman (9H-pyrido[3,4-b]indole) and har-
man (1-methyl-9H-pyrido[3,4-b]indole) are formed in the
pyrolysis of tryptophan and are shown to be present at
much higher levels than heterocyclic amines in tobacco
condensates and cooked foods [68, 69]. These chemicals
showed co-mutagenicity with S9 mixure in the presence
of aniline and o-toluidine. The resulting aminophenylnor-
harman (APNH), aminomethylphenylnorharman (AMPNH)
and aminophenylharman (APH) found to be produced
by coupling of norharman and aniline, norharman and
o-toluidine, and harman and aniline in the presence of S9
mixture. We examined the genotoxicity of these coupling
chemicals using umu tester strains established in our
laboratory. APNH, AMPNH and APH were found to
induce umuC gene expression in NAT2-overexpressing
strain at much higher rate than the NAT1-overexpressing
strain. The genotoxicity of APNH, AMPNH, and APH
was also detected in OY1002/1A2 strain, OY1002/1A1
and OY1002/1A2 strains, and in OY1002/1A2 strain,
respectively. The results suggested that these chemicals
were mainly bioactivated via P450 1A2 and NAT2 [70].
3-Nitrobenzanthrone (3-NBA) is a carcinogenic mutagen
existed in diesel exhaust, airborne particulate matter, soil,
and water [71]. I first constructed the S. typhimurium
OY1022 strain by selecting resistant colonies of TA1535NR
capable of growing in the presence of 1,8-dinitropyrene to
reduce the direct sensitivity to 3-NBA and established S.
typhimurium strains OY1022/1A1, OY1022/1A2, OY1022/
1B1, and OY1022/3A4 expressing four recombinant human
P450s by introducing two plasmids into the OY1022, one
carrying both P450 and NPR cDNAs in a biocistronic
construct under control of an IPTG-inducible double tac
promoter and the other, pOA102, carrying O-AT and umu-
C"lacZ fusion gene. Using these strains, we investigated
whether any human P450 enzymes are involved in the bioac-
tivation of 3-NBA to genotoxic metabolites. 3-NBA was
found to induce umuC gene expression in OY1022/1A1,
and OY1022/3A4 strains and, to lesser extent, OY1022/1A2
and OY1022/1B1 strains, at a much higher rate than the
parental OY1022/pCW strain. We demonstrated that the
activation of 3-NBA can be catalyzed by human P450 3A4,
1A1, 1A2, and 1B1 and NPR to a genotoxin in the presence
of bacterialO-AT, probably due to nitroreduction [72].
2-Phenyl benzotriazole (PBTA)-type compounds (such
as PBTA-4, PBTA-6, PBTA-7, and PBTA-8) were identi-
fied as major mutagens in blue cotton/rayon-absorbed
substances collected at sites below textile dyeing facto-
ries or municipal water treatment plants treating domes-
tic water and effluents from textile dyeing factories in
several rivers in Japan [73]. We examined the genotoxicity
of four PBTA derivatives using parental strain TA1535/
pSK1002 and O-AT-overexpressing strain NM2009. Four
PBTA derivatives induced the umuC gene expression
more strongly in the bacterial O-AT-overexpression strain
than the parental strain. We also determined the bioacti-
vation of these chemicals by recombinant human or rat
P450 enzymes in NM2009. The results showed that human
recombinant P450 1A1 enzyme was much more active than
P450 1A2 and 3A4 in the genotoxic activation of all PBTA
compounds. We further investigated the potential role of
human NATs in the activation of them using NM6000,
NM6001, and NM6002. PBTA-4 showed almost similar
sensitivity in the NAT1-expressing strain and the NAT2-
expressing strain, although NAT2-expressing exhibited
relatively higher sensitivity to PBTA-6, PBTA-7, and PBTA-
8 than NAT1-expressing strain. These results suggested
that P450 1A1 and NATs are important enzymes respon-
sible for bioactivation of PBTA-type compounds [74].
3,6-Dinitrobenzo[e]pyrene (DNBeP) is a potent muta-
gen identified in surface soil in two metropolitan area of
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Japan [75]. Using a variety of umu tester strains expressing
human P450s and NAT enzymes, we examined the role of
human P450 enzymes in the bioactivation of DNBeP to
genotoxic metabolites. The dose-dependent induction of
umuC by DNBeP was observed at concentrations between
0.01 and 1 nM in the O-AT-expressing strai, but not in the
O-AT-deficient strain. In the P450 3A4-, P450 1A2-, P450
1A1-and P450 1B1-expressing strains, DNBeP was found
to be activated to reactive metabolites that cause the induc-
tion of umuC gene expression compared with the parental
strain. The induction of DNBeP in the NAT2-expressing
strain had a 10-fold lower concentration than that in the
NAT1-expressing strain. We suggested that nitroreduction
by human P450 1A2, P450 3A4, and P450 1A1 and
O-acetylation by human NAT2 contributes to the bioacti-
vation of DNBeP [76].
Human sulfotransferases
Sulfonate conjugation has been shown to be an important
pathway in the biotransformation of numerous xenobiotics
and endobiotics such as drugs, chemical carcinogens, hor-
mones, bile acids, neurotransmitters, peptides, and lipids
[77]. Sulfotransferases (SULTs) transfer the sulfate moieties
from the cofactor 3′-phosphoadenosine-5′-phosphosul-
phate (PAPS) to nucleophilic groups of their substrates.
In the case of most xenobiotics and small endogenous
substrates, sulfonation has generally been considered as a
detoxification process leading to more water-soluble pro-
ducts and thereby facilitating their excreation via kidney
or bile [78]. However, for xenobiotics such as N-hydroxy
arylamines, N-hydroxy heterocyclic amines, hydroxymethyl
polycyclic aromatic hydrocarbons, the enzymes activate
them to highly reactive sulfate esters that bind covalently to
DNA [79]. In humans, SULTs consist of four familes,
namely SULT1, 2, 4 and 6 and contain at least 13 members
of proteins [80]. SULT 1A1, 1A2, 1A3, 1C2, 1E1, and 2A1
are the major enzymes to catalyze the conjugation of xeno-
biotic chemicals including carcinogens [81].
We developed a newly umu assay system to investigate
the roles of three different human SULTs, namely SULT
1A1, 1A2, and 1A3, in the bioactivation of aromatic amines,
nitroarene compounds, benzylic and allylic alcohols, and
estrogens-like compounds to genotoxins [11]. In order to
express the three different SULT enzymes in S. typhimu-
rium, I subcloned human SULT 1A1, 1A2, and 1A3 cDNA
genes into the multicopy plasmid vector pTrc99AKM. The
generated plasmids were introduced into the S. typhimu-
rium O-AT-deficient strain NM6000 (TA1538/1,8-DNP/
pSK1002), resulting in the tester strains NM7001, NM7002,
and NM7003 (Table 3). These test systems are highly sen-
sitive for SULT-dependent carcinogens without external
supply of the cofactor PAPS and MgSO4. We compared
the sensitivities of three strains with the parental strain
NM7000 against 51 chemicals with and without S9 mix.
2-Amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC) and
Glu-P-1 exhibited strong genotoxicity in the strain NM7001
in the presence of liver S9 mix compared with the strains
NM7002, NM7003 and NM7000 (Table 5). The results were
consistent with Glatt et al. [82] who reported that MeAαC
showed strongly enhanced mutagenicity in a S. typhimu-
rium strain expressing SULT 1A1 in the presence of rat liver
postmitochondrial fraction compared with a control strain.
Furthermore, in the case of Glu-P-1, Chu et al. [83] showed
that N-hydroxy-Glu-P-1 was selectively sulfonated by a
human liver thermostable phenol SULT purified from
human liver, probably SULT 1A1 or a mixture of SULT
1A1 and 1A2. These results suggested that human SULT
1A1 is involved in the bioactivation of MeAαC and
Glu-P-1 to genotoxic metabolites. On the contrary, 2-AA,
2-acetylaminofluorene, and 2-amino-1-methyl-6-pheny-
limidazo[4,5-b]pyridine (PhIP) exhibited stronger geno-
toxicity in the strain NM7002 compared with the strains
NM7001 and NM7003. The results were in agreement
with reports by Glatt and colleague, suggesting that the
N-hydroxy-2-acetylaminofluorene is activated most effi-
ciently by SULT 1A2 expressed in S. typhimurium [84].
Arylamines such as 2-AA, 4-aminobiphenyl, APNH, and 3-
methoxy-4-aminoazobenzene showed a similar genotoxic
potential in strains NM7001 and NM7002, suggesting that
these chemicals are bioactivated by SULT 1A1 and 1A2.
NM7001, NM7002, and NM7003 strains were found to be
of similar sensitivities toward 2-amino-9H-pyrido[2,3-b]
indole and β-naphthylamine. In cases of 6-aminochrysene,
MeIQ, Trp-P-1, and 3-amino-1-methyl-5H-pyrido[4,3-b]
indole, all strains used showed similar sensitivities (Table 6).
Of the 15 nitroarenes, 5-nitroacenaphthene, 3-nitrobe
nzanthrone (3-NBA), and 3,9-dinitrofluoranthene showed
the highest genotoxic potential in the strain NM7001
(Table 6). Arlt et al. [85] reported that human SULT 1A1
is involved in the formation of DNA adducts by 3-NBA
using Chinese hamster lung cell line that expresses human
SULT 1A1. This finding is consistent with our results that
3-NBA is bioactivated by human SULT 1A1.
The strain NM7002 was highly sensitive to 2-nitro
fluorene, 1-nitropyrene and 2-nitropropane. However, in
the case of other nitroarenes such as furylfuramide, 3-ni
trofluoranthene, nitrofurazone, 1-nitronaphthalene, 4-nit
roquinoline 1-oxide, 2-nitrotriphenylene, 3,7-dinitroflu
oranthene, and 1,6-dinitropyrene, the genotoxicity was
almost equal in all strains (Table 6).
Among numerous benzylic alcohols, 1′-hydroxysafrole
and estragole were strongly activated in the strain NM7003
that expresses the human SULT 1A3 (Table 6). The result
was the first evidence that human SULT 1A3 plays an
important role in the metabolic activation of benzylic alco-
hols to genotoxic intermediates.
Finally, we showed as well that the genotoxic potency
of several chemicals is reduced by SULT enzymes. For
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example, the genotoxicity of Glu-P-1, PhIP, 2-nitrofluo
rene, 3-nitrofluoranthene, 1-nitropyrene, and 3,7-dinitro
fluoranthene was inhibited by SULT 1A3. In the case of
acrolein, the genotoxicity was inhibited by SULT 1A1
and 1A3. These findings suggested that SULT 1A1 or
SULT 1A3 enzymes were involved in the detoxification of
several genotoxic compounds. The umu test system with
over-expressed human SULT enzymes may provide to be
useful for a further investgation of the SULT-function in
the metabolic inactivation of carcinogens.
In summary, using these strains exhibiting phase II
human NATs as well as SULTs, we demonstrated that
these assay systems provides a sensitive means of assessing
the genotoxicity of procarcinogens requiring activation by
these enzymes, and useful tools for studying the role of
human drug enzymes in biotransformation of xenobiotic
chemicals.
Development of a high-throughput umu-microplate test
system
Because chemical mutagens and carcinogens are present in
the environment in minute quantities, the development of
small-scale, rapid and sensitive bioassay system is required
for the detection of these environmental genotoxines. We
newly developed a rapid umu-microplate test system that
used S. typhimurium strains TA1535/pSK1002, NM2009,
and NM3009 to detect genotoxic activity in small-volume
samples. The results indicated that the genotoxicity was
detected mainly in the fine fraction but also partially in the
coarse fraction. The pattern of the response suggested that
the genotoxic activity of the particulate extract was due
primarily to nitrated polycyclic aromatic hydrocarbons. As
an application of the assay, we demonstrated that the assay
could be determined the genotoxicity of atomospheric pati-
culate extracts and the microplate test assay may be useful
tool for genotoxicity in small-volume environmental sam-
ples [86, 87]. As other examples, Ma et al. [88] performed
in conjunction with analytical measurements to identify
potential genotoxins in river and adjacent ground waters in
Jialu river basin, China. The genotoxicity was identified by
using LC-MS/MS analysis that flumequine was one of the
causal agents. In addition, the specific response to NM3009
compared with TA1535/pSK1002 demonstrated the pres-
ence of nitroarenes in the river sample, although the extract
chemicals could not be identified by analyzing the potential
nitroarenes commonly detected in the environment. Since
the identification of major putative genotoxic compounds
in most surface waters with high genotoxic activity in the
world has not been performed, further efforts on chemical
isolation and identification by bioassay-directed chemical
analysis should be performed. Recently, Tian et al. [89] eva-
luated the applicability of BugBuster Master Mix (B. M.
mix) for umu test to compare the performance with that of
the sodium dodecyl sulfate-Z-buffer system in detecting the
Table 6 Comparison of substrate specificity of human
sulfotransferases expressed in S. typhimurium TA1538/1,8-DNP/
pSK1002 towards a variety of chemicals [11]
Chemicals S9 SULT isoforms
Arylamines
2-Aminoanthracene + 1A1 = 1A2
2-Aminofluorene + 1A2
2-Acetylaminofluorene + 1A1 < 1A2
4-Aminobiphenyl + 1A1 = 1A2
6-Aminochrysene + SR
Aminophenylnorharman + 1A1 < 1A2
AαC + 1A3 = 1A2 < 1A1
Glu-P-1 + 1A1
IQ + SR
MeAαC + 1A2 < 1A1
MeIQ + SR
3-MeO-AAB + 1A1 = 1A2
β-Naphthylamine + 1A3 < 1A2 = 1A1













4-Nitroquinoline 1-oxide − SR
2-Nitrotriphenylene − SR
4,4′-Dinitrobiphenyl − 1A1 = 1A2
3,7-Dinitrofluoranthene − 1A2 < 1A1
3,9-Dinitrofluoranthene − 1A2 < 1A1
1,6-Dinitropyrene − SR
Benzylic and allylic alcohols
Estragole + 1A3
Hycanthone − 1A1 = 1A3
1′-Hydoxysafrole − 1A3
1-Hydroxymethylpyrene − 1A3 < 1A2 < 1A1
SR presents same response in all strains
AαC, 2-amino-9H-pyrido[2,3-b]indole; Glu-P-1, 2-amino-6-methyl-dipyrido[1,2-
α:3′,2′-d]imidazole; IQ, 2-amino-3-methylimidazo[4,5-f]quinoline; MeAαC, 2-
amino-3-methyl9H-pyrido[2,3-b]indole; MeIQ, 2-amino-3,5-dimethylimidazo[4,5-
f]quinoline; 3-MeO-AAB, 3-methoxy-4-aminoazobenzene; PhIP, 2-amino-1-me-
thyl-6-phenylimidazo[4,5-b]pyridine; Trp-P-1, 3-amino-1,4-dimethyl-5H-pyr-
ido[4,3-b]indole; Trp-P-2, 3-amino-1-methyl-5H-pyrido[4,3-b]indole
Oda Genes and Environment  (2016) 38:24 Page 10 of 14
genotoxicity of some pure chemicals and various environ-
mental water samples. The results indicated that B. M.
Mix, as an effective enzyme extraction reagent, could
increase the sensitivity of the umu test. Ozonation was
also found to be effective in removing genotoxicity from
wastewater, whereas chlonination of the reclaimed water
led to the increase of genotoxicity.
Application of umu test to photogenotoxicity and flow
cytometry analysis
An increasing number of compounds are proven to be
photo-genotoxic, although the mechanism of action on
DNA varies with the compounds. The photo-genotoxicity
can now be detected by various assay systems [90]. I esta-
blished tester strains NM8001 and NM8021 by introducing
the pSK1002 plasmid into strains YG3001 and YG3002,
respectively. We selected six compounds that are known to
be photo-genotoxic [8-methoxypsoralen (8-MOP), chlor-
promazine (CPZ), methylene blue (MB), neutral red (NR),
dichlorobenzidine (DCB), 9,10-dimethylbenzanthracene
(DMBA)] and evaluated them using the 96-well protocol of
the umu test after UVA irradiation with the original strain
S. typhimurium TA1535/pSK1002 as well as NM8001 and
NM8021 [12]. The latter two strains are highly sensitive to
oxidative DNA damage owing to the deletion of the nucleo-
tide excision repair enzyme uvrB and the base excision
repair enzyme mutY, and the nucleotide excision repair
enzyme uvrB and the base excision repair enzymes mutY
and mutM, respectively. Among the compounds tested
under UVA irradiation, 8-MOP, CPZ, and DMBA showed a
significant induction of β-galactosidase activity in NM8001
and NM8021 strains whereas MB, NR, and DCB showed
only a slight increase in the β-galactosidase level. The acti-
vity of NM8001 induced by the photo-genotoxins was quite
similar to that of NM8021, suggesting that the deficiency of
mutY did not affect detection of the selected photo-
genotoxins. These results indicated that the photo-irradiated
96-well version of the umu test can be used for rapid screen-
ing of the photo-genotoxicity of compounds.
Atmospheric and room temperature plasma (ARTP)
mutagenesis has been used for the mutation breeding of
more than 40 microorganisms. However, ARTP mutagen-
esis has not been quantitatively compared with conven-
tional mutation methods. Recently, we developed umu
test using a flow-cytometric analysis to quantify the DNA
damage caused by ARTP, UV, and chemical (4-NQO
and MNNG) treatments in individual viable cells using S.
typhimurium NM2009 as the model strain and to deter-
mine the mutation rate [13]. The mutation rate was found
to be proportional to the corresponding SOS response
induced by DNA damage. Although the conventional
umu test was used to detect the genotoxicity to both dead
and viable cells, regardless of the type of DNA damage, in
this study, we concluded that umu test using flow cytome-
try can quantitatively measure DNA damage with viable
cells.
Conclusion
In this review, I described that the umu test has been used
for detecting potential DNA-damaging agents during three
decades. The main advantages of this test may be practical.
A single strain S. typhimurium TA1535/pSK1002 is used.
A quantitative colorimetric response is completed in a few
hours. The manipulations are performed with very simpli-
city since only test tubes or microplates are required and
need not be done under strict sterile conditions. In
addition, the umu test can use for the detection of strong
cytotoxic compounds to bacteria such as antineoplastic
drugs (bleomycin, doxorubicin, mitomycin C). Further-
more, this test is applicable to the kinetic analysis of enzy-
matic activation of chemical carcinogens by several drug-
metabolizing enzymes. Moreover, it may be a useful com-
plement to the Ames test for screening of genotoxic carci-
nogens. We have established numerous umu tester strains
by introducing various genes encoding metabolic enzymes
for genotoxic bioactivation, including bacterial NR and
O-AT, phase I enzymes human P450s, phase II enzymes rat
GST, human NATs and SULTs. However, although the
modification of umu test systems expressing mammalian
metabolic enzymes has been mentioned in above sections,
there still is much room for further improvements in the
umu test system. Several genes have been ever introduced
into the umu assay systems. For example, co-expression
systems in the same cell for P450s and other enzymes
involved in the metabolic activation and inactivation of
genotoxins might be developed for the estimation of the
mechanistic roles of the enzymes. They are also appropriate
for a high-throughput genotoxicity screening. For example,
hydroxylation of arylamines and heterocyclic amines and
their subsequent O-acetylation or sulfation may be carried
out by catalysis of P450 1A2 and NAT1/2 or SULT 1A1/
1A2 enzymes. These test systems could provide valuable
screening tools for genotoxicity in numerous fields and also
be appropriate for basic studies on the possible roles of
respective enzymes. In addition, these systems have the
following many advantages: they are simple, rapid, small
sample volumes with a few μl, and are ideally suited for
high-throughput applications. Thus, umu test systems
could be able to use for validation of genotoxicity assays as
well as for studying of the mechanisms of biotransform-
ation of chemicals that may be genotoxic to humans.
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